Bioengineering & Translational Medicine
Aims and Scope
Bioengineering & Translational Medicine is an official, peer-reviewed, online, open access journal of the American Institute of Chemical Engineers (AIChE) and its technological community, the Society for Biological Engineering (SBE).
Bioengineering & Translational Medicine is focused on the fundamental ways chemical and biological engineering approaches drive and provide innovative technologies and solutions that impact clinical practice and/or commercial healthcare products. The journal includes research reports, reviews, and rapid communications with a focus on biomolecular engineering advances.
Topics covered in Bioengineering & Translational Medicine include:
- Drug delivery
- Drug discovery and development
- Tissue engineering
- Chemical engineering-based bioprocessing
- Synthetic biology
- Organoids and organ-mimetic systems
- Stem cell therapies
- Gene therapies
- Patient-targeted therapies
- Medical devices
- Regenerative medicine
- Implant/patient interface
- Computational modeling
Open Access and Copyright
All articles published by Bioengineering &Translational Medicine are fully open access: immediately freely available to read, download and share. All articles are published under the terms of the Creative Commons Attribution (CC-BY) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. Copyright on any research article in a journal published by Bioengineering & Translational Medicine is retained by the author(s). Authors grant Wiley a license to publish the article and identify itself as the original publisher. Authors also grant any third party the right to use the article freely as long as its integrity is maintained and its original authors, citation details and publisher are identified. Further information can be found on our open access license and copyright page.
Peer Review Policy
Peer review is conducted with scientific independence, quality and speed as guiding principles. Reviewer identity is not revealed at any stage unless explicitly requested by the reviewer. All reviewers should read the AIChE Ethical Guidelines.